Skip to main content
. 2019 May 9;3(1):e000385. doi: 10.1136/bmjpo-2018-000385

Table 1.

Baseline characteristics of both groups showing a balanced sample without significant differences between the groups

Baseline characteristics Group with hypotonic solution
n=151
Group with isotonic solution
n=143
P value
Age in months* 21, 3–109 18, 2–110 0.13†
Age in months*
 <12
 12–24
 >24
21, 3–109
56
53
45
18, 2–110
67
40
38
0.13†
Sex
 Male
73 59 0.22‡
Time at study enrolment* 6±3.2 5±2.6 0.43†
Serum sodium concentrations on admission ​​(mEq/L) 142 (141–145) 143 (139–146) 0.75†
Potassium values ​​(mEq/L) 4 (3.4–4.4) 3.9 (3.5–4.8) 0.71†
Glucose values ​​in blood (mg/dL) 121 (109–171) 134 (110–168) 0.69†
Blood pH on admission 7.41 (7.35–7.45) 7.402 (7.39–7.51) 0.67†
Total volume infused by weight (mL/kg/day) 69 (45.2–90.3) 105 (35.8–112.8) 0.62†
Diagnosis Total
N=294
Group with hypotonic solution
n=151
Group with isotonic solution
n=143
P value
Asthma 13 6 7 0.11‡
Acute respiratory infectious disease 109 53 56 0.72‡
Postbone marrow transplant 23 14 11 0.66‡
Postsurgical
 Neurosurgical 21 10 11 0.78‡
 Thoracic 25 11 14 0.26‡
 Abdominal 34 19 12 0.77‡
Oncological chemotherapy plan 37 23 13 0.54‡
Seizure disorder 32 15 19 0.86‡

*Median, IQR (25–75).

†Wilcoxon test.

‡Pearson’s χ2 test.